Mark S Leventhal, a director of ProPhase Labs, recently acquired 6,295 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on January 02, 2015. Leventhal now owns 461,980 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of
his pecuniary interest therein.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!